Rep. April McClain Delaney Sells Bio-Techne Corp Stock

The Democratic representative from Maryland disclosed the stock sale in a recent filing.

Apr. 9, 2026 at 9:20am

Got story updates? Submit your updates here. ›

An extreme close-up of gears, levers, and other heavy machinery components, representing the complex infrastructure of the banking industry.The intricate inner workings of the financial system, captured in a striking industrial portrait.Minneapolis Today

Representative April McClain Delaney (Democratic-Maryland) recently sold between $1,001 and $15,000 worth of shares in Bio-Techne Corp (NASDAQ:TECH). The sale was disclosed in a filing on April 6th and occurred on March 26th.

Why it matters

As a member of Congress, Representative McClain Delaney is subject to strict rules around stock trading and financial disclosures to avoid conflicts of interest. This sale of Bio-Techne stock is noteworthy as it involves a sitting member of the House of Representatives.

The details

Bio-Techne Corp is a global life sciences company that develops and sells reagents, instruments and services for research, diagnostic and bioprocessing markets. The company's stock opened at $55.21 on Thursday and has traded between $46.01 and $72.16 over the past 52 weeks.

  • Representative McClain Delaney disclosed the stock sale in a filing on April 6, 2026.
  • The stock sale occurred on March 26, 2026.

The players

Representative April McClain Delaney

A Democratic member of the U.S. House of Representatives, representing Maryland's 6th Congressional District. She assumed office in January 2025 and is running for re-election in 2026.

Bio-Techne Corp

A global life sciences company that develops and sells reagents, instruments and services for research, diagnostic and bioprocessing markets. The company is publicly traded on the NASDAQ under the ticker symbol TECH.

Got photos? Submit your photos here. ›

What’s next

The House Ethics Committee may review the stock sale to ensure it complies with congressional financial disclosure rules.

The takeaway

This stock sale by a sitting member of Congress highlights the ongoing scrutiny and regulations around lawmakers' personal financial activities, which are intended to prevent conflicts of interest and maintain public trust.